Tillis backs protection for pharmaceutical firms – News & Observer (blog)

Tillis backs protection for pharmaceutical firms
News & Observer (blog)
Sen. Thom Tillis has been trying to work out a compromise on a patent reform bill. The compromise would benefit the pharmaceutical industry by carving out an exemption from a streamlined review process for FDA-approved drugs. During his campaign forĀ …

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd